Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Net Income history
Currency unavailable · from the cash flow
No Net Income data reported for this period type.
Net Income vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $875.31M USD | -15.4% | +38.4% | 76.9% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 284.34M SEK | -6.1% | +15.9% | 21379.2% |
| LTM Mar 2026 | $23.91M USD | -179.4% | — | 6.6% | |
| LTM Mar 2026 | $3.58M USD | -140.0% | +31.8% | 3.1% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -77.7% | +31.8% | 41.8% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.